An investigator received $4,000 of consulting income from a publicly traded drug company over the past 12 months. The investigator also owns stock in that company valued at $2,000. The investigator is submitting a grant to the National Institutes of Health that involves evaluating the effectiveness of a drug produced by the same drug company. What is true?

The investigator has to disclose that he has a significant financial interest with that specific drug company. Whenever an investigator has more than $5,000 ($2,000 + $4,000 = $6,000) in stock and/or consulting income from a single company, it must disclose that relationship when it is applying for NIH funding.

Answer Link